The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours
Background: Breast cancer (BC) is a heterogeneous disease characterised by variant biology and patient outcome. The amino acid transporter, SLC7A5, plays a role in BC although its impact on patient outcome in different BC subtypes remains to be validated. This study aimed to determine whether the cl...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
BioMed Central
2018
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/49955/ |